A New Bipartisan Bill Could Clear the Way for CBD Supplements

A bipartisan group of lawmakers introduced a bill in the U.S. House of Representatives on Monday that would give the Food and Drug Administration (FDA) flexibility to allow hemp-derived cannabidiol (CBD) to be sold as a dietary supplement, boosting shares of cannabis stocks such as Charlotte's Web Holdings (OTC: CWBH.F), which was up 18% today on the news.

House Agriculture Committee Chairman Collin Peterson, D-Minn., filed the bill amending the Federal Food, Drug, and Cosmetic Act (FD&C), and it is co-sponsored by James Comer, R-Ky.; Chellie Pingree, D-Maine; and Thomas Massie, R-Ky.

Peterson said in a press release, "This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products." The bill would also require the Department of Agriculture to produce a report on the regulatory and market barriers faced by hemp farmers.

Continue reading

Source Fool.com